Panm Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.90 Cr
- Satisfied Charges ₹ 5.27 Cr
- Revenue Growth %
- Profit Growth -614.31%
- Ebitda -368.61%
- Net Worth -5.06%
- Total Assets -23.10%
About Panm Biotech
Panm Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 December 2003 and has a history of 21 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.90 Cr. The company has closed loans amounting to ₹5.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bijender Kumar and Parveen Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2003PTC123361
-
Company No.
123361
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Dec 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Panm Biotech Private Limited offer?
Panm Biotech Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Panm Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bijender Kumar
|
Additional Director | 25-Sep-2023 | Current |
|
Parveen Kumar
|
Additional Director | 31-Aug-2023 | Current |
Financial Performance of Panm Biotech.
Panm Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 614.31% decrease in profit. The company's net worth dipped by a decrease of 5.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panm Biotech?
In 2019, Panm Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mawasi Enterprises Private LimitedBijender Kumar and Parveen Kumar are mutual person
Charges (Loans)
₹2.90 Cr
₹5.27 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of Inadia : 2.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2007 | Union Bank Of Inadia | ₹2.90 Cr | Open |
| 26 Mar 2010 | Allahabad Bank | ₹7.71 M | Satisfied |
| 26 Mar 2010 | Allahabad Bank | ₹4.50 Cr | Satisfied |
How Many Employees Work at Panm Biotech?
Panm Biotech has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panm Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panm Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
